Cargando…

Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer

Patients with gastric cancer (GC) have a poor prognosis, which is mainly due to the low rate of early diagnosis. The present study aimed to evaluate whether circulating microRNA-130b (miR-130b) and blood routine parameters [neutrophil count (N#), lymphocyte count (L#), monocyte count (M#), neutrophi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianlin, Liu, Zhaohui, Gao, Gan, Mo, Yuandong, Zhou, Hongling, Huang, Wenjie, Wu, Lihua, He, Xiaoling, Ding, Junping, Luo, Changjun, Long, Haihua, Feng, Jingrong, Sun, Yifan, Guan, Xiaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371962/
https://www.ncbi.nlm.nih.gov/pubmed/34429765
http://dx.doi.org/10.3892/ol.2021.12986
_version_ 1783739746021801984
author Chen, Jianlin
Liu, Zhaohui
Gao, Gan
Mo, Yuandong
Zhou, Hongling
Huang, Wenjie
Wu, Lihua
He, Xiaoling
Ding, Junping
Luo, Changjun
Long, Haihua
Feng, Jingrong
Sun, Yifan
Guan, Xiaoyong
author_facet Chen, Jianlin
Liu, Zhaohui
Gao, Gan
Mo, Yuandong
Zhou, Hongling
Huang, Wenjie
Wu, Lihua
He, Xiaoling
Ding, Junping
Luo, Changjun
Long, Haihua
Feng, Jingrong
Sun, Yifan
Guan, Xiaoyong
author_sort Chen, Jianlin
collection PubMed
description Patients with gastric cancer (GC) have a poor prognosis, which is mainly due to the low rate of early diagnosis. The present study aimed to evaluate whether circulating microRNA-130b (miR-130b) and blood routine parameters [neutrophil count (N#), lymphocyte count (L#), monocyte count (M#), neutrophil percentage (N%), lymphocyte percentage (L%), monocyte percentage (M%), hemoglobin (Hb) level, hematocrit (Hct), red blood cell distribution width (RDW), platelet count, platelet distribution width (PDW), mean platelet volume (MPV), MPV to platelet count ratio (MPV/PC), monocyte to lymphocyte ratio (MLR), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR)] are useful biomarkers for GC, early stage GC (EGC) and precancerous lesion (Pre) detection, and to identify more effective diagnostic models by combining circulating blood markers. Circulating levels of M#, M%, RDW-coefficient of variation (RDW-CV), MPV, PDW, MLR and NLR were significantly higher, and the levels of Hb and L% were significantly lower in patients with GC and Pre compared with those in healthy controls (NCs) (all P<0.05). The N#, N% and PLR in patients with GC were significantly higher and the Hct was significantly lower than those in the NCs (all P<0.05). The values of MPV/PC were significantly higher in the Pre cohort compared with those in the NCs. The area under the curve (AUC) of the receiver operating characteristic curve of potential biomarkers for GC was 0.634–0.887 individually, and this increased to 0.978 in the combination model of miR-130b-PDW-MLR-Hb. Additionally, the values for RDW-CV, PLR, NLR, N# and N% were positively correlated with cancer stage, while the values for MPV, L#, L%, Hb and Hct were negatively correlated with cancer stage. Furthermore, the circulating levels of miRNA-130b, and the values for NLR, RDW-CV, PDW, M%, red blood cell count, Hct, Hb and MLR differed between the EGC and NC groups. The AUC values of these biomarkers were 0.6491–0.911 individually in the diagnosis of EGC, and these increased to 0.960 in combination. In addition, the AUC values for miR-130b, RDW-CV, MPV/PC ratio, MLR, NLR, PDW, L%, M%, M# and Hb in the diagnosis of Pre were 0.638–0.811 individually. The dual-model of miR-130b-PDW manifested the largest AUC of 0.896 in the diagnosis of Pre, and the sensitivity and accuracy were increased when miR-130b and PDW were combined. All these results suggested that circulating miR-130b and blood routine parameters might be potential biomarkers, and combinations of measurements of these biomarkers may improve the GC, EGC and Pre diagnostic accuracy.
format Online
Article
Text
id pubmed-8371962
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-83719622021-08-23 Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer Chen, Jianlin Liu, Zhaohui Gao, Gan Mo, Yuandong Zhou, Hongling Huang, Wenjie Wu, Lihua He, Xiaoling Ding, Junping Luo, Changjun Long, Haihua Feng, Jingrong Sun, Yifan Guan, Xiaoyong Oncol Lett Articles Patients with gastric cancer (GC) have a poor prognosis, which is mainly due to the low rate of early diagnosis. The present study aimed to evaluate whether circulating microRNA-130b (miR-130b) and blood routine parameters [neutrophil count (N#), lymphocyte count (L#), monocyte count (M#), neutrophil percentage (N%), lymphocyte percentage (L%), monocyte percentage (M%), hemoglobin (Hb) level, hematocrit (Hct), red blood cell distribution width (RDW), platelet count, platelet distribution width (PDW), mean platelet volume (MPV), MPV to platelet count ratio (MPV/PC), monocyte to lymphocyte ratio (MLR), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR)] are useful biomarkers for GC, early stage GC (EGC) and precancerous lesion (Pre) detection, and to identify more effective diagnostic models by combining circulating blood markers. Circulating levels of M#, M%, RDW-coefficient of variation (RDW-CV), MPV, PDW, MLR and NLR were significantly higher, and the levels of Hb and L% were significantly lower in patients with GC and Pre compared with those in healthy controls (NCs) (all P<0.05). The N#, N% and PLR in patients with GC were significantly higher and the Hct was significantly lower than those in the NCs (all P<0.05). The values of MPV/PC were significantly higher in the Pre cohort compared with those in the NCs. The area under the curve (AUC) of the receiver operating characteristic curve of potential biomarkers for GC was 0.634–0.887 individually, and this increased to 0.978 in the combination model of miR-130b-PDW-MLR-Hb. Additionally, the values for RDW-CV, PLR, NLR, N# and N% were positively correlated with cancer stage, while the values for MPV, L#, L%, Hb and Hct were negatively correlated with cancer stage. Furthermore, the circulating levels of miRNA-130b, and the values for NLR, RDW-CV, PDW, M%, red blood cell count, Hct, Hb and MLR differed between the EGC and NC groups. The AUC values of these biomarkers were 0.6491–0.911 individually in the diagnosis of EGC, and these increased to 0.960 in combination. In addition, the AUC values for miR-130b, RDW-CV, MPV/PC ratio, MLR, NLR, PDW, L%, M%, M# and Hb in the diagnosis of Pre were 0.638–0.811 individually. The dual-model of miR-130b-PDW manifested the largest AUC of 0.896 in the diagnosis of Pre, and the sensitivity and accuracy were increased when miR-130b and PDW were combined. All these results suggested that circulating miR-130b and blood routine parameters might be potential biomarkers, and combinations of measurements of these biomarkers may improve the GC, EGC and Pre diagnostic accuracy. D.A. Spandidos 2021-10 2021-08-10 /pmc/articles/PMC8371962/ /pubmed/34429765 http://dx.doi.org/10.3892/ol.2021.12986 Text en Copyright: © Chen et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Chen, Jianlin
Liu, Zhaohui
Gao, Gan
Mo, Yuandong
Zhou, Hongling
Huang, Wenjie
Wu, Lihua
He, Xiaoling
Ding, Junping
Luo, Changjun
Long, Haihua
Feng, Jingrong
Sun, Yifan
Guan, Xiaoyong
Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer
title Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer
title_full Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer
title_fullStr Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer
title_full_unstemmed Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer
title_short Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer
title_sort efficacy of circulating microrna-130b and blood routine parameters in the early diagnosis of gastric cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371962/
https://www.ncbi.nlm.nih.gov/pubmed/34429765
http://dx.doi.org/10.3892/ol.2021.12986
work_keys_str_mv AT chenjianlin efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT liuzhaohui efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT gaogan efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT moyuandong efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT zhouhongling efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT huangwenjie efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT wulihua efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT hexiaoling efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT dingjunping efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT luochangjun efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT longhaihua efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT fengjingrong efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT sunyifan efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer
AT guanxiaoyong efficacyofcirculatingmicrorna130bandbloodroutineparametersintheearlydiagnosisofgastriccancer